Skip to main content
Clinical Trials/NCT04856163
NCT04856163
Completed
Not Applicable

The Impact of Telelactation Services on Breastfeeding Outcomes: Digital Tele-MILC Trial

RAND1 site in 1 country2,108 target enrollmentJuly 8, 2021
ConditionsBreastfeeding

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breastfeeding
Sponsor
RAND
Enrollment
2108
Locations
1
Primary Endpoint
Breastfeeding Duration 1
Status
Completed
Last Updated
last year

Overview

Brief Summary

This project will assess the impact of a novel breastfeeding support intervention ("telelactation"), delivered via video calls on personal devices including mobile phones and tablets. The goal of this intervention is to increase access to International Board Certified Lactation Consultants to improve, and reduce disparities in, breastfeeding rates. By implementing a digital randomized controlled trial that recruits participants through a popular pregnancy tracker mobile phone application, this mixed methods study will recruit a national sample of 1800-2400 individuals (depending on rate of attrition) during their third trimester of pregnancy to 1) provide evidence on the effectiveness of a widely available, yet understudied, service and 2) leverage technology to promote one of the most widely recommended health behaviors to improve children's health and to reduce disparities in key maternal and child health outcomes.

Detailed Description

This study is a pragmatic, parallel design randomized controlled trial that will generate evidence on the impact of telelactation on breastfeeding duration and exclusivity and explore differences in effectiveness by race/ethnicity. The study is mixed methods, and uses a sequential explanatory design in which qualitative interviews are used to explain and contextualize findings from the quantitative outcomes analysis. We will recruit primiparous, pregnant individuals age \> 18 who intend to breastfeed and live in states most underserved by IBCLCs. Recruitment will occur via Ovia, a pregnancy tracker mobile phone application (app) used by one million pregnant individuals in the U.S. annually. Participants will be randomized to: 1) on-demand telelactation video calls on personal devices or 2) ebook on infant care/usual care. Breastfeeding outcomes will be captured via surveys and interviews and compared across racial and ethnic groups. This study will track participants for eight months (including six months postpartum), generating 1) quantitative data on the impact of telelactation and differences in effectiveness across racial and ethnic minority groups; and 2) rich qualitative data on the experiences of different subgroups of parents with the intervention, including barriers to use, satisfaction, and strengths and limitations of this delivery model.

Registry
clinicaltrials.gov
Start Date
July 8, 2021
End Date
December 31, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
RAND
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • ≥ 18 years of age
  • pregnant with first child
  • intend to attempt breastfeeding
  • residing in a state underserved by IBCLCs

Exclusion Criteria

  • non-singleton pregnancy
  • advised by healthcare provider not to breastfeed for a medical reason (e.g., HIV+ status, chemotherapy planned)
  • in police custody or incarcerated
  • infant to be separated from birthing parent (e.g., given up for adoption, military deployment)

Outcomes

Primary Outcomes

Breastfeeding Duration 1

Time Frame: 6 months postpartum

Number of participants who report any breastfeeding at 6 months

Breastfeeding Duration 2

Time Frame: 6 months post-partum

Time to cessation of breastfeeding in months (as measured by reported age of infant when completely stopped receiving breastmilk)

Breastfeeding Exclusivity

Time Frame: 6 months postpartum

Number of participants who report no formula use at 6 months

Secondary Outcomes

  • Breastfeeding Satisfaction(6 months postpartum)

Study Sites (1)

Loading locations...

Similar Trials